Search research articles
Contact Us
Filters
Showing results (141-150 of 170) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2016
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
Jeffrey C Thompson, Stephanie S Yee, Andrea B Troxel, et al.
JTO Clinical and Research Reports
|
April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
Jeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
Ramaswamy Govindan, Charu Aggarwal, Scott J Antonia, et al.
Oral Oncology
|
March 4, 2022
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers
Robert M Brody, David Shimunov, Roger B Cohen, et al.
Clinical Lung Cancer
|
April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System
Nikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
Nikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Cancer
|
January 31, 2024
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era
Michelle Iocolano, Nikhil Yegya-Raman, Cole Friedes, et al.
JCO Oncology Practice
|
July 3, 2024
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial
Melina E Marmarelis, Dylan G Scholes, Tara L McWilliams, et al.
Nature Medicine
|
July 10, 2023
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results
Martin Gutierrez, Wei-Sen Lam, Matthew D Hellmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
Christian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 170) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2016
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
Jeffrey C Thompson, Stephanie S Yee, Andrea B Troxel, et al.
JTO Clinical and Research Reports
|
April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
Jeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
Ramaswamy Govindan, Charu Aggarwal, Scott J Antonia, et al.
Oral Oncology
|
March 4, 2022
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers
Robert M Brody, David Shimunov, Roger B Cohen, et al.
Clinical Lung Cancer
|
April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System
Nikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
Nikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Cancer
|
January 31, 2024
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era
Michelle Iocolano, Nikhil Yegya-Raman, Cole Friedes, et al.
JCO Oncology Practice
|
July 3, 2024
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial
Melina E Marmarelis, Dylan G Scholes, Tara L McWilliams, et al.
Nature Medicine
|
July 10, 2023
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results
Martin Gutierrez, Wei-Sen Lam, Matthew D Hellmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
Christian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Page
of 17